Role of microperimetry to detect early visual function deficits in patients with hydroxychloroquine retinal toxicity—a review
- 9 July 2025
- journal article
- review article
- Published by Springer Nature in Eye
- Vol. 39 (13) , 2509-2517
Abstract
Chloroquine and its analogue hydroxychloroquine (HCQ) are antimalarial drugs used in various rheumatological and dermatological diseases. HCQ retinal toxicity (HCQ-RT) is uncommon but early detection of retinal toxicity and prompt cessation of the medication can usually prevent significant visual function (VF) losses. The risk of retinopathy from HCQ depends on the duration of drug use, cumulative exposure to the drug, age, presence of liver or renal disease and underlying retinal disease. The screening of all patients on HCQ for early detection of retinal toxicity is recommended. Routine screening tests include structural imaging with spectral domain optical coherence tomography and fundus autofluorescence and functional testing with visual fields and electrophysiology. Functional testing is challenging as it requires patient co-operation. No single test has shown high sensitivity or specificity. Microperimetry (MP) is an emerging VF measure that allows the evaluation of mesopic and scotopic macular sensitivity by the detection of early scotomas and a change in normal fixation. It employs computerized threshold perimetry with real-time fundus imaging. This is a scoping review of the literature to provide updates on recent studies that have used MP as an ancillary diagnostic test for detecting HCQ toxicity in the retina.Keywords
This publication has 46 references indexed in Scilit:
- A NOVEL METHOD FOR SCREENING THE MULTIFOCAL ELECTRORETONOGRAM IN PATIENTS USING HYDROXYCHLOROQUINERetina, 2008
- Ocular toxicity of hydroxychloroquine.2006
- Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapyBritish Journal of Ophthalmology, 2005
- Multifocal Electroretinographic Evaluation of Long-term HydroxychloroquineUsersArchives of Ophthalmology (1950), 2004
- The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquineOphthalmology, 2003
- Detection and Prevention of Maculopathy Associated with Antimalarial AgentsInternational Ophthalmology Clinics, 1999
- Antimalarial drugs in the treatment of rheumatological diseases.Rheumatology, 1997
- Evaluation of several tests in screening for chloroquine maculopathyEye, 1989
- Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyThe American Journal of Medicine, 1983
- Chloroquine Retinopathy. Investigation of Discrepancy Between Dark Adaptation and Electroretinographic Findings in Advanced StagesAmerican Journal of Ophthalmology, 1971